Skip to main content

Table 5 Comparison between viral hepatitis and NAFLD groups according to the cutoff values of their bile acids

From: The role of serum bile acid profile in differentiation between nonalcoholic fatty liver disease and chronic viral hepatitis

  Viral hepatitis (group II) (n = 146) NAFLD (group III) (n = 39) χ2 p
No. % No. %
TCA
 ≤ 0.001 67 45.9 36 92.3 26.872* < 0.001*
 > 0.001 79 54.1 3 7.7
TCDCA
 ≤ 0.02 57 39.0 22 56.4 3.795 0.051
 > 0.02 89 61.0 17 43.6
TUDCA
 ≤ 0 59 40.4 17 43.6 0.128 0.720
 > 0 87 59.6 22 56.4
TLCA
 ≤ 0 49 33.6 17 43.6 1.349 0.245
 > 0 97 66.4 22 56.4
GCA
 ≤ 0.35 71 48.6 25 64.1 2.952 0.086
 > 0.35 57 51.4 14 35.9
GCDCA
 ≤ 1.1 73 50.0 30 76.9 9.040* 0.003*
 > 1.1 73 50.0 9 23.1
UDCA
 ≤ 0 36 24.7 20 51.3 10.337* 0.001*
 > 0 110 75.3 19 48.7
DCA
 ≤ 0.04 27 18.5 17 43.6 10.694* 0.001*
 > 0.04 119 81.5 22 56.4
LCA
 ≤ 0 61 41.8 36 92.3 31.505* < 0.001*
 > 0 85 58.2 3 7.7
  1. χ2 Chi-square test, p value for comparing between the studied groups
  2. CDCA Chenodeoxycholic acid,TCA taurocholic acid, TCDCA taurochenodeoxycholic acid, TUDCA taurodeoxycholic acid, TLCA taurolithocholic acid, GCA glycholic acid, GCDCA, UDCA ursodeoxycholic acid, DCA deoxycholic acid, LCA lithocholic acid
  3. *Statistically significant at p ≤ 0.05